PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON-COVALENT (REVERSIBLE) BTK INHIBITOR IN PREVIOUSLY TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS FROM THE PHASE 1/2 BRUIN STUDY
RRBN Presentera, N Shahb, A Alencarc, J Gersond, M Patele, W Jurczakf, K Patelg, A Matoh, C Cheahi, M Wangj
a Eli Lilly and Company (Lilly), São Paulo, SP, Brazil
b Medical College of Wisconsin, Milwaukee, United States
c Sylvester Comprehensive Cancer Center, Miami, United States
d University of Pennsylvania, Philadelphia, United States
e Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, United States
f Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
g Swedish Cancer Institute, Seattle, United States
h Memorial Sloan Kettering Cancer Center, New York, United States
i Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, Australia
j MD Anderson Cancer Center, Houston, United States
Ver másRead
1240
Timeswas read the article
571
Total PDF
669
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 May | 22 | 8 | 30 |
| 2025 April | 41 | 18 | 59 |
| 2025 March | 52 | 11 | 63 |
| 2025 February | 42 | 18 | 60 |
| 2025 January | 24 | 16 | 40 |
| 2024 December | 34 | 13 | 47 |
| 2024 November | 26 | 18 | 44 |
| 2024 October | 28 | 20 | 48 |
| 2024 September | 37 | 20 | 57 |
| 2024 August | 39 | 18 | 57 |
| 2024 July | 35 | 21 | 56 |
| 2024 June | 36 | 19 | 55 |
| 2024 May | 32 | 23 | 55 |
| 2024 April | 38 | 21 | 59 |
| 2024 March | 19 | 19 | 38 |
| 2024 February | 24 | 30 | 54 |
| 2024 January | 12 | 13 | 25 |
| 2023 December | 10 | 19 | 29 |
| 2023 November | 13 | 26 | 39 |
| 2023 October | 10 | 23 | 33 |
| 2023 September | 13 | 19 | 32 |
| 2023 August | 10 | 19 | 29 |
| 2023 July | 7 | 40 | 47 |
| 2023 June | 14 | 18 | 32 |
| 2023 May | 7 | 12 | 19 |
| 2023 April | 6 | 11 | 17 |
| 2023 March | 5 | 9 | 14 |
| 2023 February | 6 | 15 | 21 |
| 2023 January | 6 | 6 | 12 |
| 2022 December | 11 | 26 | 37 |
| 2022 November | 7 | 18 | 25 |
| 2022 October | 3 | 4 | 7 |
Show all
